PA
VEEV icon

PharVision Advisers’s Veeva Systems VEEV Stock Holding History

PharVision Advisers’s Portfolio VEEV Stock Details VEEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,447
Closed -$323K – 626
2025
Q4 		$323K Buy
1,447
+142
+11% +$37.7K 0.16% 232
2025
Q3 		$389K Sell
1,305
-500
-28% -$141K 0.22% 93
2025
Q2 		$520K Buy
1,805
+919
+104% +$228K 0.75% 5
2025
Q1 		$205K Sell
886
-1,361
-61% -$311K 0.28% 196
2024
Q4 		$472K Buy
+2,247
New +$494K 0.4% 50

Other funds holding VEEV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LP
Linonia Partnership New York $5.38B AUM 20.54% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PharVision Advisers's VEEV Position: Q1 2026 in Review

PharVision Advisers sold out of Veeva Systems (VEEV) in Q1 2026, closing a stake of 1,447 shares — an estimated $323K sold.

PharVision Advisers first reported a position in VEEV in Q4 2024 and held it in 5 quarters. The position peaked at $520K in Q2 2025. 1,017 funds tracked by Wall St. Rank hold VEEV as of Q1 2026.

  • PharVision Advisers reported no remaining Veeva Systems position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 1,447 Veeva Systems shares in Q1 2026, an estimated $323K.
  • PharVision Advisers first reported a position in Veeva Systems in Q4 2024 and held it in 5 quarters.
  • PharVision Advisers's Veeva Systems position peaked at $520K in Q2 2025.
  • 1,017 funds tracked by Wall St. Rank held Veeva Systems as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.